Conbercept Ophthalmic Injection for Patients of Central Retinal Vein Occlusion

NCT03223714 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

242

Enrollment

INDUSTRY

Sponsor class

Conditions

Macular Edema
Central Retinal Vein Occlusion

Interventions

DRUG: Conbercept Ophthalmic Injection
DRUG: sham injection

Sponsor

Chengdu Kanghong Biotech Co., Ltd.